SR&ED, IRAP and BDC: Funding a Canadian Startup

Canada’s flagship innovation subsidy is not a grant programme, it is a tax credit, and as of 2026 it is worth roughly twice what it was two years ago. The Scientific Research and Experimental Development (SR&ED) expenditure limit for the enhanced 35% refundable credit went from $3 million to $6 million, capital spending became claimable again, and the Canada Revenue Agency opened a pre-approval channel that tells you whether a project qualifies before you spend the money. Everything else in the founder’s stack (IRAP, BDC, EDC, the provincial credits) sits on top of that base, and most founders assemble it in the wrong order.

What counts as SR&ED, and what never will

SR&ED is not “R&D” in the venture-pitch sense. The CRA applies two tests. The why test asks whether the work sought new scientific or technological knowledge that was uncertain when the project began. The how test asks whether you got there by systematic investigation: defining a problem, forming a hypothesis, testing it by experiment or analysis, and drawing conclusions.

The CRA’s guidance is explicit that the credit follows the science, not the commercial outcome: what matters is whether the work “advances the understanding of science or technology, not how the work advanced your business.”

Three categories qualify (basic research, applied research and experimental development) plus support work such as engineering, design, programming and testing when directly needed by an eligible project. Failure is fine; establishing that an approach does not work is still a technological advance.

The exclusion list is where claims die. CRA rules out market research, quality control and routine testing, social sciences and humanities research, commercial production, style changes, routine data collection, and training or hiring people who already have the expertise. A startup that ports its product to a new platform using known techniques has done a lot of work and none of it is SR&ED.

Two rates, and the numbers that changed

The basic investment tax credit is 15% of qualified expenditures and is generally non-refundable, which is worth nothing to a pre-revenue company. The enhanced credit is 35% and is fully refundable on current expenditures, meaning the CRA writes a cheque whether or not you owe tax. That distinction is the whole game for startups.

The enhanced rate applies up to an annual expenditure limit. Per the CRA’s current ITC page, that limit is $3 million for tax years beginning before 16 December 2024 and $6 million for tax years beginning after 15 December 2024, a maximum enhanced credit of $2.1 million a year.

The sequence matters if you are reading older advice. The 2024 fall economic statement proposed $4.5 million, along with raising the taxable-capital phase-out band, extending the 35% rate to eligible Canadian public corporations and restoring capital expenditure eligibility. Budget 2025 then pushed the limit to $6 million for taxation years beginning on or after 16 December 2024. The enabling legislation, Bill C-15, received royal assent on 26 March 2026. Any figure written before that date is probably stale.

Two other changes are easy to miss. The 35% refundable rate is no longer CCPC-only: eligible Canadian public corporations now qualify. And capital expenditures are claimable again for depreciable property acquired after 15 December 2024, though credits on capital spending are 40% refundable rather than 100%.

A worked example

Take a CCPC with a tax year starting 1 January 2026, $5 million of qualified SR&ED expenditures and $8 million of prior-year taxable capital. Under the old rules: 35% on the first $3 million gives $1.05 million refundable, plus 15% on the remaining $2 million gives $300,000 non-refundable. Under the current rules the whole $5 million sits inside the $6 million limit, so 35% applies across the board: $1.75 million, all refundable. Same spend, $700,000 more credit, and $300,000 of dead non-refundable credit converted into cash.

The grind, and the deadline that cannot be extended

The expenditure limit is reduced by prior-year taxable capital. That threshold band moved from $10 million–$50 million to $15 million–$75 million: the limit starts shrinking once taxable capital passes $15 million and reaches nil at $75 million. A company sitting at $45 million is halfway through the band. Taxable capital is not revenue: a large cash balance from a financing round counts, which is how a well-funded startup quietly grinds down its own credit.

The filing deadline is harder than most because it is absolute. The SR&ED filing requirements policy sets the reporting deadline at 12 months after the income tax return filing due date, which for a corporation works out to 18 months after the tax year end. The CRA states plainly that it cannot by law grant additional time. Miss it and the claim is gone.

Newer, and genuinely useful: since 1 April 2026 the CRA runs a pre-claim approval process. Canadian corporations and partnerships under $25 million in annual gross income and in good standing can submit up to three planned projects through My Business Account, meet a CRA SR&ED specialist within four weeks and get a determination within eight weeks. An approval holds for up to three years, and later claims containing pre-approved projects that need expenditure review are targeted at 90 days instead of 180.

IRAP: advice is the product, money is the option

The NRC Industrial Research Assistance Program is the other federal pillar, and founders consistently misread it as a grant window. The entry point is an Industrial Technology Advisor, and the NRC says it fields more than 250 of them across Canada, providing technical and business advice, patent searches and referrals. Contribution funding follows that relationship; it is not an open application form.

Eligibility is narrow: incorporated, for-profit, operating in Canada, with up to 500 full-time-equivalent employees, developing and commercialising technology-driven products or services. Unlimited liability companies, LLCs, sole proprietorships, partnerships and co-operatives are out. IRAP does not fund day-to-day operating costs, non-technical activities, work performed outside Canada, or research with weak commercialisation prospects. One mechanical point: IRAP contributions are government assistance, and government assistance reduces the qualified expenditure pool for SR&ED.

BDC and EDC are lenders, not funders

Both are Crown corporations and neither gives money away. BDC lends and invests: its fiscal 2025 annual report records 107,345 entrepreneurs served and $11.5 billion in new loans and investments, with roughly $1 billion deployed through its Growth Venture Fund and Growth Equity Partners. It describes itself as Canada’s most active venture capital investor by transaction volume, and 68% of its portfolio is businesses with under $2 million in annual sales.

EDC is Canada’s export credit agency and matters the moment you have a US or European customer. Its lines are financing, credit insurance, bonding and guarantees (including the Export Guarantee Program, which backstops a commercial lender rather than lending directly), and market knowledge. Insuring foreign receivables is often what lets a bank advance against them at all.

Provincial credits: real money, awkward interactions

Quebec’s is the biggest structural change. The tax credit for research, innovation and commercialization (CRIC) replaced the province’s older R&D credits for tax years beginning after 25 March 2025. It pays 30% refundable on qualified expenditures above an exclusion threshold, the greater of $50,000 or the sum of the basic personal amount per eligible employee, up to $1 million, and 20% above that. It cannot be combined with the C3i investment and innovation credit on the same expenditure.

Assembling the stack in the right order

1. Incorporate as a CCPC before real technical work starts. The enhanced rate now reaches eligible public corporations too, but the CCPC route is still the default.
2. Set the fiscal year end deliberately. It fixes both your 18-month SR&ED deadline and the point at which taxable capital is measured for the grind.
3. Get an IRAP advisor engaged early. The advisory relationship, not the funding, is the asset, and contributions only follow it.
4. Use pre-claim approval for anything technically borderline. Eight weeks of certainty before you spend beats an eligibility argument two years later.
5. Keep contemporaneous technical records: hypotheses, experiments, results, and hours against each. Reconstructed narratives are where reviews go badly.
6. Layer the provincial credit, then model the interaction, since refundable provincial credits and IRAP contributions both reduce the federal pool.
7. Bring in BDC or EDC only where there is a receivable, contract or asset to lend against. They price risk; they do not subsidise it.

What to do before your next year end

If your tax year began after 15 December 2024 and your accountant is still modelling a $3 million expenditure limit, the claim is understated, possibly by several hundred thousand dollars of refundable credit. Check three things this quarter: which limit your year falls under, where prior-year taxable capital sits relative to $15 million, and whether capital equipment bought since December 2024 was left out. Then put the 18-month deadline in the calendar as a hard stop. It is one of the few in Canadian tax law the CRA has no authority to move.

Sources

• Canada Revenue Agency — Get an investment tax credit (ITC)
• Canada Revenue Agency — What work is eligible for SR&ED
• Canada Revenue Agency — SR&ED Filing Requirements Policy
• Canada Revenue Agency — SR&ED pre-claim approval process
• Government of Canada — Budget 2025, Tax measures: supplementary information
• Department of Finance Canada — Reforming and enhancing the SR&ED tax incentive programme
• National Research Council Canada — Financial support for technology innovation (NRC IRAP)
• BDC — 2025 Annual Report news release